Darmiyan

Darmiyan is Alzheimer's detection up to 15 yrs in advance. 1. Early diagnosis of Alzheimer's disease and other dementias in pre-symptomatic stages.
2. Screening brain health in the young and middle-aged population. Early prevention improves quality of life and slows brain aging.
3. Monitoring brain improvement/ cure when applying new drug candidates in clinical trials.
4. Precise characterization of distribution pathways and kinetics for novel drugs.

Customers:
1. Medical centers: These include hospitals, clinics, and private medical offices.
2. Pharmaceutical companies: These will mainly include those pharmaceutical companies that develop medication to prevent, delay, treat, or cure brain diseases such as those that cause dementia.
3. Academic research labs: Any neuroscience research lab or group studying scientific hypotheses related to brain tissue micro-structure in any way.Soma invested in seed round, with Sequoia scout fund participating as well